Skip to main content

Published locations for FDA grants "breakthrough" status to investigational T-cell therapy for relapsed/refractory ALL

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA grants "breakthrough" status to investigational T-cell therapy for relapsed/refractory ALL

User login

  • Reset your password
  • /content/fda-grants-breakthrough-status-investigational-t-cell-therapy-relapsed/refractory-all-0
  • /oncologypractice/article/84331/leukemia-myelodysplasia-transplantation/fda-grants-breakthrough
  • /hematology-oncology/article/84331/leukemia-myelodysplasia-transplantation/fda-grants-breakthrough